Related Experiment Video
Updated: Oct 30, 2025

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
Published on: April 12, 2024
Long-Term Imaging Follow-Up in DIPNECH: Multicenter Experience.
Cécile Chung1,2, Sébastien Bommart3,4, Sylvain Marchand-Adam5
1Department of Radiology, AP-HP. Centre, Hôpital Cochin, 75014 Paris, France.
Diffuse pulmonary neuroendocrine cell hyperplasia (DIPNECH) can progress over time. Long-term annual imaging follow-up is recommended to monitor disease evolution and potential metastatic spread in DIPNECH patients.
Area of Science:
- Pulmonology
- Oncology
- Radiology
Background:
- Diffuse pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare, pre-invasive lung condition with unclear pathophysiology.
- Understanding the long-term behavior of DIPNECH is crucial for developing appropriate patient management strategies.
Purpose of the Study:
- To evaluate the long-term evolution of imaging findings in patients with DIPNECH.
- To establish evidence-based recommendations for follow-up imaging in DIPNECH.
Main Methods:
- Retrospective analysis of chest CT scans from 27 histologically confirmed DIPNECH patients across four centers (2001-2020).
- Inclusion criteria required at least two CT exams separated by a minimum of 24 months.
- CT findings were analyzed for changes in lung nodules and the development of metastatic spread over a median follow-up of 63 months.
Main Results:
- Seventy percent (19/27) of patients showed an increase in lung nodule size over time.
- Eleven percent (3/27) of patients developed metastatic spread, with a mean interval of 70 months from baseline CT.
- Metastases involved mediastinal lymph nodes and/or distant sites.
Conclusions:
- DIPNECH exhibits heterogeneous longitudinal behavior, including nodule growth and delayed metastatic spread.
- Long-term annual imaging follow-up is suggested for comprehensive monitoring of DIPNECH patients.
- These findings support the need for extended surveillance protocols in managing DIPNECH.
More Related Videos
04:44Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018